Published

Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of Analytical Toxicology
Date: 2026-05-23
Source: Crossref
DOI: 10.1093/jat/bkag015
PubMed: 41723823

Authors

Bergh Marianne Skov-Skov Bogen Inger Lise Vevelstad Merete Øiestad Åse Marit Leere

Watch author

Derived topics and classifications

psilocybin psilocin Biomarkers Other

Citation graph

33 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1177/0269881121992676 10.1002/cpt.2821 10.1007/s40262-024-01454-4 10.1038/s41386-019-0324-9 10.3390/ijms21239279 10.1080/00365510510013604 10.1007/s00414-012-0796-1 10.1080/02791072.1996.10472488 10.1155/2018/1032638 10.1016/j.drugalcdep.2024.111086 10.1016/j.jchromb.2020.122486 10.1111/1556-4029.15454

Indexed papers citing this DOI

Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake2026-05-23

Related papers

Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging StudyClinicalTrials.gov · 2025-08-20 Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17 Maddening Therapies: How Hallucinogens Morphed into Novel TreatmentsCurrent psychiatry · 2017-01-01 Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term MeditatorsClinicalTrials.gov · 2014-05-20